Jenny Hamilton
LightNews LightNews
banner
jro-hamilton.bsky.social
Jenny Hamilton
@jro-hamilton.bsky.social
410 followers 570 following 2 posts
CRISPR delivery startup co-founder 👩🏼‍🔬

Previous: Doudna lab postdoc ✂️🧬 + virology PhD studies at Mount Sinai 🦠
Posts Replies Media Videos
jro-hamilton.bsky.social
Hello! Anyone on here a member of ASH? I’m looking for someone who could sponsor a late-breaking abstract. If you can help or make an intro, please DM me. Thanks! 🙏
October 27, 2025 at 2:22 AM
Reposted by Jenny Hamilton
enirenberg.bsky.social
Peter Marks’s resignation letter. Everyone should read this.
Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 March 28, 2025 Sara Brenner, MD, MPH Acting Commissioner of Food and Drugs U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 Dear Dr. Brenner: It is with a heavy heart that I have decided to resign from FDA and retire from federal service as Director of the Center for Biologics Evaluation and Research effective April 5, 2025. I leave behind a staff of professionals who are undoubtedly the most devoted to protecting and promoting the public health of any group of people that I have encountered during my four decades working in the public and private sectors. I have always done my best to advocate for their well-being and I would ask that you do the same during this very difficult time during which their critical importance to the safety and security of our nation may be underappreciated. Over the past years I have been involved in enhancing the safety of our nation's blood supply, in advancing the field of cell and gene therapy, and in responding to public health emergencies. In the last of these, during the COVID-19 pandemic I had the privilege of watching the vision that I conceived for Operation Warp Speed in March 2020 in collaboration with Dr. Robert Kadlec become a reality under the leadership of HHS Secretary Azar and President Trump due to the unwavering commitment of public servants at FDA and elsewhere across the government. At FDA, the tireless efforts of staff across the agency resulted in remarkably expediting the development of vaccines against the virus, meeting the standards for quality, safety, and effectiveness expected by the American public. The vaccines undoubtedly markedly reduced morbidity and mortality from COVID-19 in the United States and elsewhere. Many of these same individuals applied learnings from the pandemic during a flawless response helping… ongoing multistate measles outbreak that is particularly severe in Texas reminds us of what happens when confidence in well-established science underlying public health and well-being is undermined. Measles, which killed more than 100,000 unvaccinated children last year in Africa and Asia owing to pneumonitis and encephalitis caused by the virus, had been eliminated from our shores. The two-dose measles, mumps, rubella vaccine regimen (MMR) using over the past decades has a remarkably favorable benefit-risk profile. The MMR vaccine is 97% or more effective in preventing measles following the two-dose series, and its safety has been remarkably well studied. Though rarely followed by a single fever-related seizure, or very rarely by allergic reactions or blood clotting disorders, the vaccine very simply does not cause autism, nor is it associated with encephalitis or death. It does, however, protect against a potential devasting consequence of prior measles infection, subacute sclerosing panencephalitis (SSPE), which is an untreatable, relentlessly progressive neurologic disorder leading to death in about 1 in 10,000 individuals infected with measles. Undermining confidence in well-established vaccines that have met the high standards for quality, safety, and effectiveness that have been in place for decades at FDA is irresponsible, detrimental to public health, and a clear danger to our nation's health, safety. and security. In the years following the pandemic, at the Center for Biologics Evaluation and Research we have applied the same unwavering commitment to public health priorities to the development of cell and gene therapies to address both hereditary and acquired rare diseases. During my tenure as Center Director we have approved 22 gene therapies, including the first gene therapy ever to be approved in the United States. However, we know that we must do better to expedite the development of treatments for those individual suffering from any one of the thousan…
March 29, 2025 at 2:29 AM
Reposted by Jenny Hamilton
paulgbot.bsky.social
Prediction: Gene editing will be huge. This is just Internet stocks in 2000.
tweet screenshot
February 7, 2025 at 1:31 PM
Reposted by Jenny Hamilton
urnov.bsky.social
"Jennifer Doudna, the director of the Innovative Genomics Institute who shared the 2020 Nobel prize for the discovery of CRISPR gene editing, told STAT ... [1/4]
www.statnews.com/2025/02/03/t...
Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Nobel laureates are calling on the National Academies and biotech CEOs to speak out against what they see as the Trump administration's attack on science.
www.statnews.com
February 3, 2025 at 3:06 PM
Reposted by Jenny Hamilton
drewberry.bsky.social
Delighted to publish my new molecular animation:

DNA Break Repair by Homologous Recombination

youtu.be/Xe-83tBcxhs
DNA Break Repair by Homologous Recombination (2024) Drew Berry wehi.tv
YouTube video by WEHImovies
youtu.be
December 4, 2024 at 12:07 AM